HIV/AIDS and Medical Marijuana

Acquired Immunodeficiency Syndrome (AIDS) results from a disruption to the immune system, which infects a person as Human Immunodeficiency Virus (HIV), a wasting syndrome. Patients who suffer from HIV often experience nausea, loss of appetite, weight loss, and neuropathy. As the infection worsens the immune system, patients are more likely to fall victim to other infections. 

HIV is treatable with a variety of harder pharmaceutical drugs that often coincide with negative side effects. Because of cannabis' ability to ease nausea and stimulate appetite, it is thought to be a valuable treatment in fighting not only the symptoms of the condition itself, but also the side effects associated with the pharmaceutical drugs used to treat the condition. 

When it comes to HIV/AIDS, there are many clinical studies supporting this claim. A study conducted by the White House and the Institute of Medicine in 1999 said, "for patients such as those with AIDS or who are undergoing chemotherapy and who suffer simultaneously from severe pain, nausea, and appetite loss, cannabinoid drugs might offer broad-spectrum relief not found in any other single medication." This statement umbrellas many of the healing properties found in cannabis that have been discussed in other various studies on HIV/AIDS. Unfortunately, it will be difficult to conduct more efficient clinical trials on humans until marijuana is no longer classified as a Schedule 1 drug. For a more detailed look at the various studies that support medical marijuana for HIV/AIDS, look to Whaxy! http://bit.ly/1gzGSp7